Manufacturers must look to ease the headaches associated with the manufacture of mRNA-based products.

A diverse range of malaria treatments will make all the difference in the prevention of resistance.

Biopharmaceutical development is in need of a speed boost. Multi-omics could be the answer.

Is autologous cell therapy a realistic proposition for solid tumors?

Inhalers still don’t work as well as they should, but computational modeling is here to help.

AI is expanding into medicine. Are the world’s regulators ready?

Aging digital systems limit the potential of decentralized trials. It's time to rethink the technologies driving them.

How the Drugs for Neglected Diseases Initiative and the Malaysian government partnered to tackle hep C with an affordable, effective cure.

In the 20th century, physics and chemistry reshaped the world. Here’s why biology will be the game-changer in the 21st century.

What are the challenges and best practices in quality control for difficult-to-inspect products?